Abstract
ObjectivesIn late 2014, an HIV outbreak occurred in rural Cambodia among villagers who received medical injections from unlicensed medical providers, justifying the need to assess medical injection practices among those who are at risk of acquiring and/or transmitting HIV. This study examined medical injection/infusion behaviours among people living with HIV (PLWH) and those who were HIV negative in Cambodia. These behaviours should be properly assessed, especially among PLWH, as their prevalence might influence a future risk of other outbreaks.DesignA cross-sectional survey was conducted in order to examine injection behaviours and estimate injection prevalence and rates by HIV status. Unsafe injections/infusions were those received from village providers who do not work at a health centre or hospital, or traditional providers at the participant’s (self-injection included) or provider’s home. Logistic regression was performed to examine the relationship between unsafe injection/infusion and HIV, adjusting for sex, age, education, occupation, residence location and other risk factors.SettingThe survey was conducted in 10 HIV testing and treatment hospitals/clinics across selected provinces in Cambodia, from February to March 2017.ParticipantsA total number of 500 volunteers participated in the survey, 250 PLWH and 250 HIV-negative individuals.Outcome measuresMeasures of injection prevalence and other risk behaviours were based on self-reports.ResultsBoth groups of participants reported similar past year’s injection/infusion use, 47% (n=66) among PLWH and 54% (n=110) HIV-negative participants (p=0.24). However, 15% (n=11) of PLWH reported having received unsafe last injection compared with only 7% (n=11) of HIV-negative participants. In logistic regression, this association remained numerically positive, but was not statistically significant (adjusted OR 1.84 (95% CI: 0.71 to 4.80)).ConclusionsThe inclination for medical injections and infusions (unsafe at times) among PLWH and the general population in Cambodia was common and could possibly represent yet another opportunity for parenteral transmission outbreak.
Funder
UCLA Centre for AIDS Research/AIDS Institute
Reference21 articles.
1. World Health Organization . Who guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health care settings. Geneva: World Health Organization, 2016.
2. World Health Organization . Injection safety: questions and answers. 2016. Available: https://www.who.int/infection-prevention/publications/is_questions-answers.pdf?ua=1 [Accessed July 2020].
3. Unsafe injection practices by medical practitioners in South Asia associated with hepatitis and HIV outbreaks;Altaf;J Infect,2018
4. Unsafe injection practices: a potential weapon for the outbreak of blood borne viruses in the community;Gupta;Ann Med Health Sci Res,2013
5. World Health Organization . Make smart injection choices: national decision-making for safe and appropriate injections. 2017. Available: https://www.who.int/infection-prevention/tools/injections/IS_medical-treatement_leaflet.pdf?ua=1